Patients with newly diagnosed or recurrent AML display an increased expression of PRMT5, and a positive correlation is found with the expression of the leukocyte immunoglobulin-like receptor B4 (LILRB4). The gene discussed is PRMT5; the disease is acute myeloid leukemia.